Alcohol consumption and urinary concentration of 6-sulfatoxymelatonin in healthy women

被引:37
|
作者
Stevens, RG
Davis, S
Mirick, DK
Kheifets, L
Kaune, W
机构
[1] Univ Connecticut, Ctr Hlth, Dept Community Med, Farmington, CT 06030 USA
[2] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA
[3] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA
[4] Elect Power Res Inst, Palo Alto, CA USA
[5] EM Factors, Richland, WA USA
关键词
breast neoplasms; alcohol drinking; nocturnal variation; melatonin levels; melatonin metabolites; gender;
D O I
10.1097/00001648-200011000-00008
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Consumption of alcoholic beverages may suppress circulating melatonin levels at night, possibly resulting in an increase in circulating estrogen. An increased estrogen burden could increase the risk of breast cancer. This study was designed to investigate whether alcohol consumption is associated with a decrease in nighttime melatonin levels in a group of healthy women. A total of 203 randomly selected healthy women between the ages of 20 and 74 years were recruited for a broader study of the effects of exposure to power-frequency magnetic fields on nocturnal levels of urinary 6-sulfatoxymelatonin. FOE. the purposes of this analysis, data collection consisted of the following during two seasons of the year: CI) an in-person interview, (2) a dairy activity diary, and (3) nocturnal urine collection for each of 3 consecutive nights. We found that the nocturnal urinary concentration of the primary metabolite of melatonin (6-sulfatoxymelatonin) decreased in a dose-dependent manner with increasing consumption of alcoholic beverages in the preceding 24-hour period, after taking into account the independent effects on melatonin of age, hours of darkness, use of medications that affect melatonin levels, and body mass index. A categorical analysis revealed no effect of one drink, but a 9% reduction with two drinks, a 15% reduction with three drinks, and a 17% reduction with four or more drinks. It remains unknown whether such a change could affect estrogen levels or breast cancer risk.
引用
收藏
页码:660 / 665
页数:6
相关论文
共 50 条
  • [41] Urinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes
    Chen, Wei
    Cao, Hui
    Lu, Qian-Yi
    Wang, Na
    Zhao, Shu-Zhi
    Xu, Xun
    Zheng, Zhi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (07): : 4317 - 4322
  • [42] Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure
    Luis Girotti
    Manuel Lago
    Oscar Ianovsky
    Marcelo V. Elizari
    Andrés Dini
    Santiago Pérez Lloret
    Liliana E. Albornoz
    Daniel P. Cardinali
    Endocrine, 2003, 22 : 245 - 248
  • [43] Dietary correlates of urinary 6-sulfatoxymelatonin concentrations in the Nurses' Health Study cohorts
    Schernhammer, Eva S.
    Feskanich, Diane
    Niu, Caroline
    Dopfel, Regina
    Holmes, Michelle D.
    Hankinson, Susan E.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2009, 90 (04): : 975 - 985
  • [44] Association of urinary levels of 6-sulfatoxymelatonin (aMT6s) with prevalent and incident hypertension
    Perez-Caraballo, Aixa M.
    Ma, Yunsheng
    Ockene, Judith K.
    Reeves, Katherine W.
    Balasubramanian, Raji
    Stanczyk, Frank Z.
    Allison, Matthew A.
    Chen, Chu
    Wang, Lu
    Manson, Joann E.
    Sturgeon, Susan R.
    CHRONOBIOLOGY INTERNATIONAL, 2018, 35 (08) : 1115 - 1121
  • [45] Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels
    Schernhammer, ES
    Kroenke, CH
    Dowsett, M
    Folkerd, E
    Hankinson, SE
    JOURNAL OF PINEAL RESEARCH, 2006, 40 (02) : 116 - 124
  • [46] Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure
    Girotti, L
    Lago, M
    Ianovsky, O
    Elizari, MV
    Dini, A
    Lloret, SP
    Albornoz, LE
    Cardinali, DP
    ENDOCRINE, 2003, 22 (03) : 245 - 248
  • [47] Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore
    Wu, Anna H.
    Stanczyk, Frank Z.
    Wang, Renwei
    Koh, Woon-Puay
    Yuan, Jian-Min
    Yu, Mimi C.
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (04) : 891 - 896
  • [48] Increased urinary 6-sulfatoxymelatonin excretion in women with non-classical steroid 21-hydroxylase deficiency
    Luboshitzky, R
    Qupti, G
    Ishay, A
    Shen-Orr, Z
    Herer, P
    NEUROENDOCRINOLOGY LETTERS, 2001, 22 (05) : 332 - 336
  • [49] No Effect of Exercise on Urinary 6-Sulfatoxymelatonin and Catecholamines in Young Women Participating in a 16-Week Randomized Controlled Trial
    Arikawa, Andrea Y.
    Thomas, William
    Patel, Sanjay R.
    Kurzer, Mindy S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (09) : 1634 - 1636
  • [50] Urinary 6-sulfatoxymelatonin Levels and Prostate Cancer Risk among Men in the Multiethnic Cohort
    Vaselkiv, Jane B.
    Cheng, Iona
    Chowdhury-Paulino, Ilkania M.
    Gonzalez-Feliciano, Amparo G.
    Wilkens, Lynne R.
    Hauksdottir, Alda M.
    Eiriksdottir, Gudny
    Le Marchand, Loic
    Haiman, Christopher A.
    Valdimarsdottir, Unnur
    Mucci, Lorelei A.
    Markt, Sarah C.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (03) : 688 - 691